Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QuerciSorb is a dietary supplement developed by Tesseract Medical Research that features the plant-derived bioflavonoid quercetin as its active ingredient. The product is distinguished by its use of the proprietary CyLoc/DexKey delivery technology, which is designed to significantly enhance the bioavailability and absorption of quercetin, a compound typically characterized by poor solubility and low systemic uptake. QuerciSorb is available in multiple formulations, including sustained-release (SR) and quick-release (QR) versions, to provide flexible dosing options. It is primarily marketed for supporting immune function, promoting cardiovascular health, and modulating inflammatory responses, particularly during seasonal environmental changes. As a nutraceutical, it is intended to support overall health and physiological function rather than to treat or cure specific medical conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QuerciSorb.